NGN Optiscan Fund II, L.P. is a private investment fund based in Stamford, Connecticut. According to its most recent Form D, filed Mar 27, 2020, it has sold $1,794,187 of interests to 26 investors since its first sale in Mar 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include NGN Capital LLC; NGN BioMed I GP, L.P.
- Total raised
- $1,794,187Cumulative sales reported on Form D
- Investors
- 26
- First sale
- Mar 4, 2019
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- NGN Capital LLC; NGN BioMed I GP, L.P
- Latest Form D
- Mar 27, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NGN Optiscan Fund II, L.P.
What is the minimum investment for NGN Optiscan Fund II, L.P.?
NGN Optiscan Fund II, L.P.'s latest Form D, filed Mar 27, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in NGN Optiscan Fund II, L.P.?
NGN Optiscan Fund II, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has NGN Optiscan Fund II, L.P. raised?
NGN Optiscan Fund II, L.P. reports $1,794,187 sold from 26 investors on its Form D filed Mar 27, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is NGN Optiscan Fund II, L.P. based?
NGN Optiscan Fund II, L.P. is based in Stamford, Connecticut.
When did NGN Optiscan Fund II, L.P. launch?
NGN Optiscan Fund II, L.P. reports its first sale in Mar 2019.
Size compared with every private investment fund
Raised more than 26% of the 306 private investment funds based in Connecticut, and more than 20% of all 10,363 that report sales.